AUS
NZ
UK
CA
USA
IND
Health
KZA Announces Superior Safety and Tolerability Data From GDC-0084’s Phase IIa Study
May 06, 2019 09:36 PM AEST| By Team Kalkine MediaKazia Therapeutics Limited (ASX: KZA) is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. On 6th May 2019, Kazia Therapeutics Limited announced new safety data from its ongoing Phase IIa study of GDC-0084 in the new...
MGC Pharma Announces Partnership with Grow Biotech and IPS
May 06, 2019 03:26 PM AEST| By Team Kalkine MediaAn EU-based BioPharma company, MGC Pharmaceuticals Ltd (ASX: MXC) is an expert in the medical cannabis industry. The company?s strategy is to deliver high-quality cannabinoids-based pharmaceuticals products in the European, North American and Austral...
A Look At Healthcare Stock - VHT
May 05, 2019 08:00 AM AEST| By Team Kalkine MediaVolpara Health Technologies Limited (ASX: VHT) is a health sector company of New Zealand and a leading provider of breast imaging analytics and analysis products that deliver personalised breast cancer screening software applications. The AI imaging...
How Are Investor’s Eyeing These Healthcare Stocks – CSL, RMD, COH, NAN
May 04, 2019 08:00 AM AEST| By Team Kalkine MediaCSL Limited (ASX: CSL) CSL Limited (ASX: CSL) is engaged in the business of biopharmaceutical and allied products with R&D, manufacturing, marketing and distribution. Basically, the group operates through two segments ? (1) CSL Behring: focuses...
Noxopharm Advances One-Step up on Its Cancer Management Program
May 03, 2019 07:00 PM AEST| By Team Kalkine MediaUnearthing the long-lasting responses with Veyonda? in the treatment of prostate cancer Clinical-stage drug development company, Noxopharm Limited (ASX: NOX) lately announced the 6-month interim results from the dose-escalation arm of the DARRT-1 st...
Favourable for IPD: ASBrS Releases PREVENT Abstract; BIS Found Effective
May 03, 2019 04:42 PM AEST| By Team Kalkine MediaImpediMed Limited (ASX: IPD) is engaged in the business of production and designing of medical devices with BIS (Bioimpedance Spectroscopy) technologies to non-invasively measure, manage and monitor tissue composition and fluid status. The company to...
Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited
May 03, 2019 04:17 PM AEST| By Team Kalkine MediaToday, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...
Healthcare Company, PolyNovo Achieved Its First Million-Dollar Month
May 03, 2019 04:08 PM AEST| By Team Kalkine MediaPolyNovo Limited (ASX: PNV) is an ASX listed healthcare company based in Melbourne, Australia. The company specialises in developing and manufacturing unique biodegradable polymers which are used in medical devices. Biodegradable Temporising Matrix (...
ResMed Shares Skyrocketed On Solid Quarterly Results For Q3 FY19
May 03, 2019 02:06 PM AEST| By Team Kalkine MediaResMed Inc.(NYSE: RMD, ASX: RMD) shares surged up over 9% in mid-day trade after the company announced 12% year-over-year growth in its revenue for the third quarter of Fiscal Year 2019. The stock is trading at $16.210, up 9.527%, as at 3 May 2019 (1...
Anteo’s Battery & Life Sciences Division Making Excellent Progress With AnteoCoat™ And AnteoBind™
May 03, 2019 01:08 PM AEST| By Team Kalkine MediaAnteo Diagnostics Limited (ASX: ADO), a company from the Health Care sector that is into the business of Developing and commercializing medical products provided an update on commercial engagements in the Battery and Life Sciences division. The comp...
MGC Pharmaceuticals Signed Two Agreements With Health House And Cannvalate
May 03, 2019 01:04 PM AEST| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC) is an ASX listed healthcare company based in Europe. The company has vast experience in the biopharma industry. Its primary business strategy is to develop and supply high-quality cannabinoid-based pharmaceuticals p...
AdAlta Announces Completion of Confirmation Run for Manufacturing of AD-214
May 02, 2019 02:00 PM AEST| By Team Kalkine MediaToday, on 2nd May 2019, the biotechnology company AdAlta Limited (ASX: 1AD) announced that it is well on track with the development of AD-214 (a lead program) for Idiopathic Pulmonary Fibrosis, following the successful completion of a confirmation ru...
BD1 Bags Patent For ‘Regulation Of BARD1 Expression By Non-Coding RNA’; Stock Surges 17%
May 01, 2019 08:46 PM AEST| By Team Kalkine MediaBARD1 Life Sciences Limited (ASX:BD1), a health sector company and biotechnology colonist, is focussed at commercialising and developing a blood test for the detection of lung cancer. This revolution that the company aims to process is technology cen...
Orthocell’s Shares Rose On ASX Post Application To TGA For Approval Of CelGro®
May 01, 2019 06:21 PM AEST| By Team Kalkine MediaOrthocell Limited (ASX: OCC) helps in the restoration of mobility and formation of soft tissue. The company also focuses on providing different new approaches to the formation of tendon, cartilage and the repair of soft tissue injuries. The company...
Zelda Therapeutics Unveils Latest Quarterly Results
May 01, 2019 01:49 PM AEST| By Team Kalkine MediaZelda Therapeutics Limited (ASX: ZLD) is an ASX listed pharmaceutical company having an interest in the cannabis market and is based in Australia. It aims to treat a variety of medical conditions using cannabinoid-based formulations. Currently, the c...
EBOS Announces ~NZ$150 Million Equity Placement To Provide Further Capacity For Growth
April 30, 2019 08:17 PM AEST| By Team Kalkine MediaToday, on 30th April 2019, EBOS Group Limited (ASX: EBO) updated to the market that its securities have been placed in a trading halt at the request of the company due to pending it releasing an announcement. At the time of such development, the stoc...
ImpediMed Signed $1.3 Million in Total Contract Value for SOZO® During Q3 FY19
April 30, 2019 06:41 PM AEST| By Team Kalkine MediaImpediMed Limited (ASX: IPD) works under the health care sector and is into the development and sale of the ImpediMed medical devices internationally. The company?s headquarter is situated in Brisbane. It has operations in the US and Europe as well.....
A Quick Review of Nanollose and Estrella March Quarter Reports
April 30, 2019 12:44 PM AEST| By Team Kalkine MediaNanollose Limited and Estrella Resources Limited released their quarterly reports on 29 April 2019 for the quarter ending 31 March 2019. Nanollose Limited An innovative firm based in Australia, Nanollose Limited (ASX: NC6) is engaged in producing ?...
Cellmid Released Q3 FY2019 Cash Flow Report, Company On Track For FY2020 Profitability.
April 29, 2019 09:45 PM AEST| By Team Kalkine Media?Cellmid Limited (ASX: CDY) is an Australian life sciences accelerator from the health care sector, with lead programs in various disease indications.? On 29th April 2019, Cellmid Limited released its quarterly cash flow report for the quarter ended...
Healthia Announced The Appointment Of Its New CEO; Stock Zoomed Up
April 29, 2019 08:54 PM AEST| By Team Kalkine MediaHealthia Limited (ASX: HLA) is an ASX listed healthcare company based in Queensland, Australia. The company aims to deliver world-class health services to enrich the lives of people. The company has a portfolio of a few healthcare companies including...
Advertise your brand on Kalkine Media